Stomatognathic Diseases: News and Research on Nasopharyngitis

MeSH tree: C07.550.350.700

FDA approves generic Emflaza oral suspension for Duchenne muscular dystrophy

The U.S. Food and Drug Administration has approved the first generic version of Emflaza (deflazacort) oral suspension for Duchenne muscular dystrophy (DMD). Approval of the generic version of Emflaza oral suspension was granted ...

Jun 17, 2024

0

0

FDA approves Dupixent for prurigo nodularis

The U.S. Food and Drug Administration approved Dupixent (dupilumab) as the first treatment for adults with prurigo nodularis, according to Regeneron Pharmaceuticals.

Oct 3, 2022

0

4